Amyloid-beta, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data

Isabelle Bos*, Stephanie J. B. Vos, Willemijn J. Jansen, Rik Vandenberghe, Silvy Gabel, Ainara Estanga, Mirian Ecay-Torres, Jori Tomassen, Anouk den Braber, Alberto Lleo, Isabel Sala, Anders Wallin, Petronella Kettunen, Jose L. Molinuevo, Lorena Rami, Gael Chetelat, Vincent de la Sayette, Magda Tsolaki, Yvonne Freund-Levi, Peter JohannsenGerald P. Novak, Inez Ramakers, Frans R. Verhey, Pieter Jelle Visser, Alzheimer's Disease Neuroimaging Initiative

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number193
Number of pages11
JournalFrontiers in Aging Neuroscience
Volume10
DOIs
Publication statusPublished - 25 Jun 2018

Keywords

  • Alzheimer's disease
  • amyloid-beta
  • tau
  • cognition
  • neuropsychological examination
  • normative data
  • PRECLINICAL ALZHEIMERS-DISEASE
  • CEREBROSPINAL-FLUID BIOMARKERS
  • DIAGNOSTIC-CRITERIA
  • INTERNATIONAL WORKSHOP
  • DEMENTIA
  • IMPAIRMENT
  • ADULTS
  • AGE
  • DECLINE
  • PARTICIPANTS

Cite this